from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3152/nuoH

LFCtreatmentdescriptionclass of inhibitor

-1.049

Amikacinug/mL Amikacintranslation

-1.510

Cap5-10ug/mL Capreomycintranslation

-2.242

Rox10-50 ug/mL Roxithromycintranslation

-0.255

SM2-5 ug/mL Streptomycintranslation

-0.624

Tet5-10 ug/mL Tetracyclinetranslation

0.240

Rif0.2-5ug/mL Rifampicintranscription

-1.258

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.083

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.353

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.328

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.029

Clofazimine10-13 ug/mL Clofaziminerespiration

0.511

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.072

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.867

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.985

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.647

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.185

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.395

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.495

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.826

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.164

Nigericin50 uM Nigericinrespiration

-0.740

TRC10-150 ug/mL Triclosanrespiration

0.617

TRZ10-25 ug/mL Thioridazinerespiration

-0.251

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.268

menadione6-10 ug/mL Menadionerespiration

-1.127

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.409

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.180

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.690

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.488

NRP_1Non-replicating persistence stage 1dosRassociated

0.769

Amp0.2mg/mL AmpicillincellWall

0.070

Cephalexin20-100 ug/mL CephalexincellWall

-0.444

Cerulenin0.32-5 ug/mL CerulenincellWall

0.834

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.028

EMB10-20 ug/mL EthambutolcellWall

-0.331

Eta12-40 ug/mL EthionamidecellWall

-1.043

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.606

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.092

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.144

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.460

BZA0.12 mg/mL BenzamidearomaticAmides

0.824

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.434

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.018

H2O24 mM hydrogen peroxideDNAdamaging

-0.348

Levo10 ug/mL LevofloxacinDNAdamaging

0.736

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.082

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.359

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.915

UVUV-irradiationDNAdamaging

-0.406

ARP41-4 ug/mL Antitubercular compound ARP4?

0.489

Antimycin12.5-50 ug/mL Antimycin A?

0.014

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.498

PA_110-50 ug/mL Antitubercular compound PA-1?

0.676

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.548

PA8240.2-2 ug/mL PA-824?

-0.651

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.743

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.568

Verapamil50 uM Verapamil?

-0.052

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.233

methoxatin10-20 ug/mL Methoxatin?